检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵嵌嵌[1,2] 张维东[1] 武利存[1] 王兆朋[1] 张月英[1] 张璐璐[1,2] 王朝霞[1]
机构地区:[1]山东省医学科学院基础医学研究所病理室,山东省罕见病重点实验室,山东济南250062 [2]济南大学山东省医学科学院医学与生命科学学院,山东济南250062
出 处:《中草药》2015年第9期1343-1347,共5页Chinese Traditional and Herbal Drugs
基 金:国家自然科学基金资助项目(81073102,30873408);山东省自然科学基金资助项目(ZR2010HQ003);国家青年科学基金项目(81303077,81403150)
摘 要:目的探讨蝎毒多肽提取物(PESV)联合雷帕霉素(RAPA)对H_(22)肝癌肿瘤血管生成的抑制作用并探讨可能的作用机制。方法 40只昆明小鼠,皮下接种H_(22)肝癌肿瘤细胞悬液建立荷瘤模型,随机分为模型组、PESV组(20 mg/kg)、RAPA组(2.5 mg/kg)和PESV+RAPA组(联合组),每组10只。连续药物干预14 d,隔日测量肿瘤体积,记录肿瘤生长曲线,计算抑瘤率。免疫组织化学法检测各组肿瘤组织的哺乳动物雷帕霉素靶蛋白(mTOR)、缺氧诱导因子-1α(HIF-1α)和血管内皮生长因子-A(VEGF-A)蛋白表达水平。以Ⅷ因子标记肿瘤微血管,计算微血管密度(MVD)。结果连续药物治疗14d后,PESV组、RAPA组、联合组肿瘤生长速度较模型组明显减慢(P<0.05、0.01),抑瘤率分别为17.7%、29.2%、44.8%。与模型组相比,3个给药组的mTOR、HIF-1α、VEGF-A的蛋白表达量降低(P<0.05、0.01),MVD不同程度降低(P<0.05、0.01)。联合组肿瘤体积以及蛋白表达量均低于RAPA组(P<0.05、0.01)。结论 PESV联合RAPA能够抑制H22肝癌小鼠肿瘤血管的生成,其作用机制可能与抑制肿瘤微环境中mTOR、HIF-1α、VEGF-A的蛋白表达有关。Objective To study the inhibition ofpolypeptide extract from scorpion venom (PESV) combined with Rapamycin (RAPA) on angiogenesis of H22 hepatoma and its mechanism. Methods The H22 carcinoma cell suspension was subcutaneously inoculated into 40 Kunming mice. Thern tumor-beating mice were randomly divided into four groups, i.e., control group, PESV group (20 mg/kg), RAPA group (2.5 mg/kg), and PESV + RAPA group, 10 mice in each group. The intervention was lasted 14 d. The tumor volume was measured once every other day, the tumor volume growth curve was drawn, and the tumor inhibitory rate was calculated. The protein expression levels of mammal target of RAPA (mTOR), hypoxia-inducible factor-1α (HIF-1α, and vascular endothelial growth factor-A (VEGF-A) were detected by immunohistochemical assay. Microvessel was signed by factor Ⅷ and then detected by immunohistochemical assay. Results The growth speed of 1-122 hepatoma transplantation tumor was obviously inhibited in the PESV group, RAPA group, and PESV + RAPA group compared with control group after 14 d intervention (P 〈 0.05, 0.01), and the tumor inhibitory rates were 17.7%, 29.2%, and 44.8%. Immunohistochemical assay showed that the protein expression of roTOR, HIF-1α, and VEGF-A in the three drug groups was reduced compared with the control group (P 〈 0.05, 0.01 ), and the MVD was reduced at different levels (P 〈 0.05, 0.01). The tumor volume and the protein expression in PESV + RAPA group are lower than those in RAPA group. Conclusion PESV + RAPA could promote the inhibition on angiogenesis of H22 hepatoma, the mechanism maybe related to the inhibition on the protein expression ofmTOR, HIF- 1α, and VEGF-A.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.171